Skip to main content

Thomas R. Burton, III

board member, career services

Thomas Burton"I believe that the Alumni Association’s new structure will force the Board to be more active in alumni outreach and bridge the gap between the Law School and its graduates. The Board will be creating engagement within the alumni base, which will, in turn, create a stronger environment for career services and fundraising. Traditionally we were a Boston centric school and over the years we’ve far exceeded those boundaries. In the interest of continuing this expansion, engaging alumni is critical."


Tom Burton is a member in the Corporate practice of Mintz Levin. He is founder and chair of
the firm’s Energy and Clean Tech Practice Group and co-chair of the Boston Office Hiring Committee. 

 
Tom regularly represents emerging growth Energy and Clean Technology and Life Sciences companies as well as larger established public companies. He routinely counsels clients on their growth and development, advises their boards of directors and participates in an array of transactions, from private and public offerings to merger and acquisitions and technology transfer matters. Tom’s practice also includes organizing venture capital funds and representing them in their portfolio investments

 

Tom’s corporate finance experience has included completing over 100 venture capital and private equity financings, which raised over a billion dollars, representing both the funds providing the capital and the emerging growth companies seeking funding. Tom has been involved in the formation, financing and sales of numerous energy and clean technology companies in markets such as clean coal, biofuels, energy and demand management, solar, wind, fuel cells and other distributed generation technologies. Representative transactions also include advising a Fortune 500 global company with respect to the multi-billion dollar international outsourcing of its information technology functions, the recapitalization of a public company and the complex merger of three biotechnology companies into a fourth public biotechnology company.

  
Tom is also experienced in advising investment banks in private placements and underwritten public offerings of equity securities and in their role as financial advisor in mergers and acquisitions.

 


Next slide